Pharma major Sun Pharmaceutical Industries Limited announced the acquisition of minority stake in Agatsa Software Private Limited and Remidio Innovative Solutions Private Limited.
According to the company’s exchange filing, “This is to inform you that Sun Pharmaceutical Industries Limited (which includes its subsidiaries and/or associate companies) [“Company”], has entered into agreements to acquire minority stake in the following entities which are non-material investments by the Company in the allied areas. 1. Agreement to acquire equity shares (up to 26.09%) of Agatsa Software Private Limited, which is is an early-stage digital diagnostic devices company. 2. Agreement to acquire equity shares (27.39%) of Remidio Innovative Solutions Private Limited, which provides innovative products enabling early detection of eye diseases.”
Agatsa Software Private Limited is engaged in research, development and commercialization of medical devices in the diagnostic health segment by leveraging technology and R&D capabilities. The Company was incorporated on 16 March, 2010.
Remidio Innovative Solutions Private Limited provides innovative products enabling early detection of eye diseases. The Company was incorporated on 19 November, 2009. The Company has a subsidiary ‘Remidio Innovation Solutions Inc’ in USA and ‘Medios Technologies Pte. Ltd in Singapore.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.